Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients
Status:
Completed
Trial end date:
2010-07-07
Target enrollment:
Participant gender:
Summary
This is a randomized, prospective and multicenter phase IV clinical trial, which has been
designed as a phase III study. One hundred fifty-four women (77 per treatment arm) will be
recruited in the study.